One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events

BACKGROUND: Warfarin is the predominant oral anticoagulant used for the prevention of recurrent venous thromboembolism (VTE) events. However, its long-term use is complicated by the need to manage the drug within a narrow therapeutic range and by possible food and drug interactions.Objective: To exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shih-Yin, Wu, Ning, Gulseth, Michael, LaMori, Joyce, Bookhart, Brahim K., Boulanger, Luke, Fields, Larry, Schein, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437455/
https://www.ncbi.nlm.nih.gov/pubmed/23627575
http://dx.doi.org/10.18553/jmcp.2013.19.4.291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437455/
https://www.ncbi.nlm.nih.gov/pubmed/23627575
http://dx.doi.org/10.18553/jmcp.2013.19.4.291

Ejemplares similares